Molecular Partners AG (MOLN)
4.044
-0.01
(-0.15%)
USD |
NASDAQ |
Jan 21, 16:00
4.05
+0.01
(+0.15%)
After-Hours: 20:00
Molecular Partners Cash from Investing (Quarterly): 14.54M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BeOne Medicines Ltd. | -49.28M |
| AC Immune SA | 26.82M |
| CRISPR Therapeutics AG | -119.23M |
| Addex Therapeutics Ltd. | 0.0379M |
| NewCelX Ltd. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.74M |
| Cash from Financing (Quarterly) | -0.3899M |
| Free Cash Flow | -62.21M |
| Free Cash Flow Per Share (Quarterly) | -0.3422 |
| Free Cash Flow to Equity (Quarterly) | -12.42M |
| Free Cash Flow to Firm (Quarterly) | -12.79M |
| Free Cash Flow Yield | -41.43% |